What's breaking now, across thousands of outlets.
Key PointsAmgen maintains a robust presence in oncology and rare diseases with a 9.9% revenue growth rate in FY 2025.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
CFO Kaur discusses $18.7B revenue growth and $1.9B in simplification savings.
Rental revenue surged 12% on mega project demand and specialty fleet mix improvements.
“Flypaper Lyda” and “Lady Bluebeard”—that’s the legacy left by Lyda Trueblood, one of Idaho’s most infamous female murderers.
New research reveals how smaller, more intentional eating occasions are creating new opportunities for nutrition, flavor and renewed enjoyment.
The Saudi main stock index rose 224.67 points to 9,986.45, with trading value reaching SAR 7.1 billion, according to the daily economic bulletin.
After the euphoria over the planned IPO of Anthropic, the momentum at the US markets is slowing down somewhat. Investors are focusing on new company figures and the Middle East.
